No video
Research Update: Copper-ATSM (CuATSM)
Рет қаралды 890
Күн бұрынDr. Joseph Beckman of OSU's Linus Pauling Institute and Dr. Peter Crouch at the University of Melbourne in Victoria, Australia join us to share the latest updates on their investigation into the novel use of Copper-ATSM (CuATSM) to slow the progression of ALS.
@ebenburger111 3 жыл бұрын
Fascinating. Interesting that Yeast such as Saccharomyces cerevisiae has a High affinity to Copper. Yeast Fermentations is a fascinating area to study as we know that Fermentations can greatly elevate the absorption level of minerals and nutrients.
@fourshore502 3 жыл бұрын
This is fascinating. Do you think CuATSm could be combined with Nurown and AMX0035?
@ourcollectiveinsanity 3 жыл бұрын
of course it can, very different mechanisms of action but both beneficial
@shefaliverma6609 3 жыл бұрын
When this drug come....pls approach...Is this costly?
@ourcollectiveinsanity 3 жыл бұрын
@@shefaliverma6609 its not a drug, its copper, you need to check your copper levels and then buy the copper atsm in case you have a deficiency, something pretty common in people with als.
@shefaliverma6609 3 жыл бұрын
@@ourcollectiveinsanity ...I cant understood...cu Atsm treats ALS right...
@shefaliverma6609 3 жыл бұрын
Pls tell me that phase 3 trial of Cu Atsm is completed or not
Dan Sfera
Рет қаралды 345 М.
The Linus Pauling Institute
Рет қаралды 13 М.
Dhru Purohit
Рет қаралды 474 М.
Florida Training Academy
Рет қаралды 134 М.
University of Minnesota
Рет қаралды 1,3 М.